Parkinson’s, Overactive Bladder Meds May Raise Dementia Risk

Parkinson’s Meds, Antipsychotics May Raise Dementia Risk

A new study published in the British Medical Journal has found that several common medications, such as anticholinergic drugs, heighten the risk of dementia by an alarming 30%.

Researchers collected data from the UK’s Clinical Practice Research Database where they identified 40,770 patients, aged 65 to 99, who were diagnosed with dementia between April 2006 and July 2015.

To assess whether anticholinergic drugs are associated with an increased risk of dementia, researchers compared patients who were prescribed specific classes of anticholinergic drugs (examples includes Parkinson’s medications and antipsychotics) 4 to 20 years before being diagnosed with dementia to nearly 300,000 people who didn’t have the disease.

The results indicated that patients who took anticholinergics used to treat depression, Parkinson’s and a bladder disorder for more than a year had around a 30% increased risk of developing dementia later on in life. However, those taking other classes of anticholinergics for the treatment of asthma and gastrointestinal issues did not have a heightened risk of developing dementia.

“For the urological and antidepressants, there’s quite a clear association between their long-term use and dementia incidence” lead study author George Savva, PhD, University of East Anglia School of Health Sciences, told CNN. “For anti-Parkinson’s medications, the risk is there, but there’s far fewer of those prescriptions in the database, so there’s a lot less certainty.”


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement